S&P 500 7,753 +2.01% Nasdaq 26,605 +2.67% Dow Jones 53,976 +1.50% FTSE 100 10,862 +0.04% DAX 26,324 +1.24% Nikkei 225 66,970 +4.71% Hang Seng 25,729 -0.48% WTI Crude 82.40 +6.61% Gold 4,439 +4.65% US 10-Year Treasury Yield 4.699 +1.56% S&P 500 7,753 +2.01% Nasdaq 26,605 +2.67% Dow Jones 53,976 +1.50% FTSE 100 10,862 +0.04% DAX 26,324 +1.24% Nikkei 225 66,970 +4.71% Hang Seng 25,729 -0.48% WTI Crude 82.40 +6.61% Gold 4,439 +4.65% US 10-Year Treasury Yield 4.699 +1.56%

LATEST

Molbio Diagnostics IPO Day 2: Issue subscribed 1.22 times so far. Check GMP, size, & other details - Apply or not?●Ardee Industries IPO listing on Wednesday; GMP signals healthy listing pop. Details here●NUPRC: Local refineries receive 53.7 million barrels of crude in Q2 2026●Technocraft Ventures IPO Day 3: Issue subscribed 7.35x so far. Check GMP, key dates, review. Apply or not?●PC Jeweller share price jumps 6% as Q1FY27 profit surges 37% YoY, revenue up 21%●4 Vedanta Group stocks to see inflows worth $160 million in Nifty September rejig. What investors must know●Bitcoin’s BIP-110 fork is 300 blocks behind BTC and six years from fixing itself●School uniform rules must go further, charity says●Molbio Diagnostics IPO Day 2: Issue subscribed 1.22 times so far. Check GMP, size, & other details - Apply or not?●Ardee Industries IPO listing on Wednesday; GMP signals healthy listing pop. Details here●NUPRC: Local refineries receive 53.7 million barrels of crude in Q2 2026●Technocraft Ventures IPO Day 3: Issue subscribed 7.35x so far. Check GMP, key dates, review. Apply or not?●PC Jeweller share price jumps 6% as Q1FY27 profit surges 37% YoY, revenue up 21%●4 Vedanta Group stocks to see inflows worth $160 million in Nifty September rejig. What investors must know●Bitcoin’s BIP-110 fork is 300 blocks behind BTC and six years from fixing itself●School uniform rules must go further, charity says●

Asia

Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?

Markets-Economic Times · 1h ago · 🇮🇳 India

Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?

Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth prompted Elara Securities to raise its earnings estimates, the brokerage downgraded the stock to ‘Accumulate’ from ‘Buy’ after its 40% three-month rally, citing limited near-term upside.

Read the full story at Markets-Economic Times →

More Asia

Molbio Diagnostics IPO Day 2: Issue subscribed 1.22 times so far. Check GMP, size, & other details - Apply or not?

mint - markets · 39m ago

Ardee Industries IPO listing on Wednesday; GMP signals healthy listing pop. Details here

mint - markets · 43m ago

Technocraft Ventures IPO Day 3: Issue subscribed 7.35x so far. Check GMP, key dates, review. Apply or not?

mint - markets · 43m ago

PC Jeweller share price jumps 6% as Q1FY27 profit surges 37% YoY, revenue up 21%

Markets-Economic Times · 44m ago